Precigen (PGEN) Current Deferred Revenue (2016 - 2026)
Precigen has reported Current Deferred Revenue over the past 14 years, most recently at $517000.0 for Q4 2025.
- Quarterly Current Deferred Revenue fell 12.22% to $517000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $517000.0 through Dec 2025, down 12.22% year-over-year, with the annual reading at $517000.0 for FY2025, 12.22% down from the prior year.
- Current Deferred Revenue was $517000.0 for Q4 2025 at Precigen, down from $575000.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $26.9 million in Q1 2021 and troughed at $15000.0 in Q2 2023.
- The 5-year median for Current Deferred Revenue is $1.8 million (2022), against an average of $6.2 million.
- Year-over-year, Current Deferred Revenue tumbled 99.94% in 2023 and then surged 2420.0% in 2024.
- A 5-year view of Current Deferred Revenue shows it stood at $1.5 million in 2021, then grew by 23.69% to $1.8 million in 2022, then grew by 26.26% to $2.3 million in 2023, then tumbled by 74.69% to $589000.0 in 2024, then decreased by 12.22% to $517000.0 in 2025.
- Per Business Quant, the three most recent readings for PGEN's Current Deferred Revenue are $517000.0 (Q4 2025), $575000.0 (Q3 2025), and $2.2 million (Q2 2025).